91ɫƵ

header-logo
Physician Patient
Alan Nyitray, PhD

Alan G. Nyitray, PhD

Associate Professor

Locations

  • Department of Psychiatry and Behavioral Medicine
    Center for AIDS Intervention Research (CAIR)
    91ɫƵ Cancer Center

Contact Information

Education

PhD, Epidemiology, Mel and Enid Zuckerman College of Public Health, University of Arizona
MS, Mass Communications, Oklahoma State University
BS, Radio, Television, and Film, Oklahoma State University

Biography

Dr. Nyitray's primary research interest is in screening interventions for human papillomavirus (HPV)-associated disease with a focus on anal cancer. This research covers anal cancer and precancer screening interventions that seek to help gay, bisexual, and other men who have sex with men detect precancers or early invasive cancer when the cancer is much more treatable. His research initially focused on the epidemiology and natural history of HPV infection and HPV antibodies, estimating the prevalence, incidence, persistence, duration of infection, clearance, and the transmission potential of HPV among heterosexual men, gay and bisexual men, and heterosexual couples. Dr. Nyitray is also interested in creating HPV vaccine interventions to increase uptake of vaccination in adults.

Research Areas of Interest

  • Anus Neoplasms
  • Early Detection of Cancer
  • Epidemiology
  • HIV
  • Mass Screening
  • Molecular Epidemiology
  • Papillomavirus Infections
  • Sexual and Gender Minorities
  • Sexual Behavior
  • Sexual Health

Research Interests

Human papillomavirus

Anal cancer

Publications

  • (Dyer CEF, Jin F, Hillman RJ, Nyitray AG, Roberts JM, Law C, Grulich AE, Poynten IM.) International Journal of Cancer. 1 January 2025;156(1):79-90 SCOPUS ID: 2-s2.0-85201078426 01/01/2025

  • (Dyer CEF, Jin F, Hillman RJ, Nyitray AG, Roberts JM, Law C, Grulich AE, Poynten IM.) Int J Cancer. 2025 Jan 01;156(1):79-90 PMID: 39140279 SCOPUS ID: 2-s2.0-85201078426 08/14/2024

  • (Nitkowski J, Ridolfi TJ, Lundeen SJ, Giuliano AR, Chiao E, Fernandez ME, Schick V, Smith JS, Bruggink P, Brzezinski B, Nyitray AG.) Sex Transm Dis. 2024 Sep 24 PMID: 39316041 SCOPUS ID: 2-s2.0-85205295776 09/24/2024

  • (Zhao J, Green C, Markham C, Fujimoto K, Nyitray AG, Hwang LY.) BMC Infect Dis. 2024 Sep 17;24(1):985 PMID: 39285350 PMCID: PMC11406739 SCOPUS ID: 2-s2.0-85204298018 09/17/2024

  • (Garg A, Damgacioglu H, Sigel K, Nyitray AG, Clifford GM, Curran T, Lazenby G, Meissner EG, Sterba K, Sonawane K, Deshmukh AA.) J Natl Cancer Inst. 2024 Sep 01;116(9):1508-1512 PMID: 38837335 PMCID: PMC11378306 SCOPUS ID: 2-s2.0-85203420030 06/05/2024

  • (Deshmukh AA, Lin YY, Damgacioglu H, Shiels M, Coburn SB, Lang R, Althoff KN, Moore R, Silverberg MJ, Nyitray AG, Chhatwal J, Sonawane K, Sigel K.) J Natl Cancer Inst. 2024 Sep 01;116(9):1450-1458 PMID: 38713084 PMCID: PMC11378305 SCOPUS ID: 2-s2.0-85203474430 05/07/2024

  • (Amboree TL, Kuo J, Sirak BA, Schneider JA, Nyitray AG, Hwang LY, Chiao EY, Giuliano AR, Fujimoto K.) Heliyon. 2024 Jun 15;10(11):e32336 PMID: 38933939 PMCID: PMC11200335 06/27/2024

  • (Ross MW, Khariwala SS, Bennis SL, Zoschke IN, Rosser BRS, Nyitray AG, Nichols CM, Flash C, Wilkerson JM, Stull CL.) Cancer Screen Prev. 2024 Jun;3(2):125-129 PMID: 39139552 PMCID: PMC11318333 08/14/2024

  • (Nitkowski J, Ridolfi TJ, Lundeen SJ, Giuliano AR, Chiao EY, Fernandez ME, Schick V, Smith JS, Brzezinski B, Nyitray AG.) Sex Health. 2024 Apr;21 PMID: 38683939 SCOPUS ID: 2-s2.0-85191911442 04/29/2024

  • (Amboree TL, Kuo J, Sirak BA, Schneider JA, Nyitray AG, Hwang LY, Chiao EY, Giuliano AR, Fujimoto K.) Heliyon. 15 June 2024;10(11) SCOPUS ID: 2-s2.0-85195171082 06/15/2024

  • (Ross MW, Bennis SL, Zoschke N, Simon Rosser BR, Stull CL, Nyitray AG, Khariwala SS, Nichols M, Flash C, Wilkerson M.) Venereology (Basel). 2023 Dec;2(4):180-193 PMID: 38515606 PMCID: PMC10956645 03/22/2024